Natural Cytotoxicity of Human Blood Lymphocytes and Monocytes and Their Cytotoxic Factors: Effect of Interferon on Target Cell Susceptibility2
- 1 November 1985
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 75 (5) , 849-857
- https://doi.org/10.1093/jnci/75.5.849
Abstract
The effect of interferon (IFN) on target cell susceptibility to human natural killer (NK) cells and monocytes was analyzed in direct cell-mediated and their cytotoxic factor-mediated cytotoxicity assays. Treatment of K562 cells with IFN resulted in a decrease in their sensitivity to lysis by nonadherent lymphocytes and Percoll-purified large granular lymphocytes (LGL) when tested in a 4-hour 51Cr release assay. In contrast, the treatment did not affect the target susceptibility to monocytes purified by adherence to autologous serum-coated plastic surfaces. In the target-binding assay with LGL or monocytes the number of conjugates was not altered after IFN treatment of K562. Lymphocytes and monocytes were induced to release soluble cytotoxic factors, termed “natural killer cytotoxic factors (NKCF) and monocyte cytotoxic factors (MCF),” respectively, when co-cultured with K562. Both NKCF and MCF lysed K562 in a 48-hour microcyto-toxicity assay or in an 18-hour 51Cr release assay in the presence of dactinomycin. IFN-treated K562 reduced or completely lost their ability to stimulate the release of NKCF, whereas they triggered MCF secretion as effectively as did the untreated K562. When lymphocytes or monocytes were pretreated with IFN, they released NKCF or MCF with augmented lytic activity. In contrast to the sensitivity to NK cell-mediated lysis, IFN pretreatment of K562 induced no change in their susceptibility to NKCF and MCF. When IFN was added to NKCF and MCF assays, the cytotoxicity was enhanced. The addition of IFN to K562 that had been pretreated with NKCF or MCF and washed resulted in no increase in lysis. The capacity of K562 to absorb the lytic activity of NKCF and MCF was not altered by IFN. These results indicate that IFN treatment of target cells can be used to distinguish the two distinct types of blood mononuclear cells with natural cytotoxicity, NK cells and monocytes, and that each effector cell type is stimulated to release cytotoxic factors by the different target determinant after the initial effector-target cell binding.Keywords
This publication has 24 references indexed in Scilit:
- Potentiation of the cytolytic activity of peripheral blood monocytes by lymphokines and interferon.The Journal of Immunology, 1983
- Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing.The Journal of Immunology, 1983
- CHARACTERISTICS AND REQUIREMENTS OF THE INTERACTION BETWEEN HUMAN-MONOCYTES AND TUMOR-CELLS ON THE SINGLE CELL LEVEL1983
- Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK-sensitive target cells (NKCF) during co-culture of NK effector cells with NK target cells.The Journal of Immunology, 1982
- Tumor cell killing by freshly isolated peripheral blood monocytesCellular Immunology, 1981
- Interferon-induced resistance of fibroblasts to cytolysis mediated by natural killer cells: specificity and mechanism.The Journal of Immunology, 1981
- Interferon-mediated protection of normal and tumor target cells against lysis by mouse natural killer cells.The Journal of Immunology, 1981
- Evidence by reactivity with hybridoma antibodies for a probable myeloid origin of peripheral blood cells active in natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity.Journal of Clinical Investigation, 1980
- Modulation of target cell susceptibility to human natural killer cells by interferonInternational Journal of Cancer, 1980
- Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.The Journal of Experimental Medicine, 1978